AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteBeta-lipotropin (beta-LPH) was found to contain within its C-terminal sequence the primary structure of these peptides.
More Information Supplier PageBeta-lipotropin (beta-LPH) was found to contain within its C-terminal sequence the primary structure of these peptides.
More Information Supplier PageBeta-lipotropin (beta-LPH) was found to contain within its C-terminal sequence the primary structure of these peptides.
More Information Supplier PageB-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 uM and 2 nM for A375 proliferation and A375 p-ERK respectively
More Information Supplier PageB-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 uM and 2 nM for A375 proliferation and A375 p-ERK respectively
More Information Supplier PageB-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 uM and 2 nM for A375 proliferation and A375 p-ERK respectively
More Information Supplier PageBAF312 is a next-generation potent sphingosine 1-phosphate (S1P) receptor agonist, selective for S1P1 and S1P5.
More Information Supplier PageBAF312 is a next-generation potent sphingosine 1-phosphate (S1P) receptor agonist, selective for S1P1 and S1P5.
More Information Supplier PageBAF312 is a next-generation potent sphingosine 1-phosphate (S1P) receptor agonist, selective for S1P1 and S1P5.
More Information Supplier PageBafetinib ((INNO-406) is a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia.
More Information Supplier PageBafetinib ((INNO-406) is a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia.
More Information Supplier PageBafetinib ((INNO-406) is a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia.
More Information Supplier PageBafetinib ((INNO-406) is a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia.
More Information Supplier PageBafetinib ((INNO-406) is a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia.
More Information Supplier PageBafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.
More Information Supplier PageBafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.
More Information Supplier PageBafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.
More Information Supplier PageBafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells.
More Information Supplier PageBaicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi. Baicalein inhibits lipid peroxidation, as assessed by production of TBARS, with an IC50 value of 5 µM.
More Information Supplier PageBaicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi. Baicalein inhibits lipid peroxidation, as assessed by production of TBARS, with an IC50 value of 5 µM.
More Information Supplier PageBaicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi. Baicalein inhibits lipid peroxidation, as assessed by production of TBARS, with an IC50 value of 5 µM.
More Information Supplier PageBaicalein is a flavonoid originally isolated from the roots of Scutellaria baicalensis Georgi. Baicalein inhibits lipid peroxidation, as assessed by production of TBARS, with an IC50 value of 5 µM.
More Information Supplier PageBaicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors.
More Information Supplier PageBaicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors.
More Information Supplier PageBaicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors.
More Information Supplier PageBaicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors.
More Information Supplier PageBaicalin is a known prolyl endopeptidase inhibitor and affects the GABA receptors.
More Information Supplier PageBakuchiol is an antioxidant inhibitor of protein tyrosine phosphatase 1B (PTP1B).
More Information Supplier PageBakuchiol is an antioxidant inhibitor of protein tyrosine phosphatase 1B (PTP1B).
More Information Supplier PageBakuchiol is an antioxidant inhibitor of protein tyrosine phosphatase 1B (PTP1B).
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBalapiravir (R1626, RG1626) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).
More Information Supplier PageBalicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
More Information Supplier PageBalicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
More Information Supplier PageBalicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
More Information Supplier PageBalofloxacin is a quinolone antibiotic. The bactericidal action of Balofloxacin results from interference with the enqyme DNA gyrase which is needed for the synthesis of bacterial DNA. Balofloxacin is efficacious against Gram-negative bacteria. It also has enhanced activity against Gram positive bacteria, including MRSA and Streptococcus pneumoniae.
More Information Supplier PageBalofloxacin is a quinolone antibiotic. The bactericidal action of Balofloxacin results from interference with the enqyme DNA gyrase which is needed for the synthesis of bacterial DNA. Balofloxacin is efficacious against Gram-negative bacteria. It also has enhanced activity against Gram positive bacteria, including MRSA and Streptococcus pneumoniae.
More Information Supplier PageBalofloxacin is a quinolone antibiotic. The bactericidal action of Balofloxacin results from interference with the enqyme DNA gyrase which is needed for the synthesis of bacterial DNA. Balofloxacin is efficacious against Gram-negative bacteria. It also has enhanced activity against Gram positive bacteria, including MRSA and Streptococcus pneumoniae.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier PageBAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.
More Information Supplier Page
